Advertisement

Symptome, Befunde und Krankheiten unter umweltmedizinischem Aspekt

Chapter

Zusammenfassung

Störungen der Hämbiosynthese können zur Porphyrie führen. Dabei ist die Überproduktion von δ-Aminolävulinsäure, Porphobilinogen und Porphyrinen kennzeichnend.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. [1]
    Bleiberg, J., Wallen, M. Brodkin, R., Applebaum, I.: Industrially acquired porphyria. Arch.Dermatol. 89, 793–797, 1964 CrossRefGoogle Scholar
  2. [2]
    Böger, A., Koss, G., Koransky, W., Naumann, R., Frenzel, H.: Rat liver alternations after chronic treatment with hexachlorobenzene. Virows Arch. A Path. Anat. and Histol. 382, 127–137, 1979 CrossRefGoogle Scholar
  3. [3]
    Cam, C.: Une nouvelle dermatose epidemique des enfants. Ann. Dermatol. 87, 393–397, 1960 Google Scholar
  4. [4]
    Cam, S., Nigogosyan, G.: Acquired toxic porphyria cutanea tarda due to hexachlorobenzene: report of 348 cases caused by this fungicide. J. Am. Med. Assoc. 183, 88–91, 1963 CrossRefGoogle Scholar
  5. [5]
    Centen, A.H.J., Strik, J.J.T.W.A., Colombi, A.: Coproporphyrinuria and chronic hepatic porphyria typ A found in people from Seveso [Italy) exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). In: Chemical Porphyria in Man, Strik, J.J. T. WA., Koeman, J.H. (Ed), Elsevier/North Holland Bionedical Press, 1979, pp. 75–81 Google Scholar
  6. [6]
    Chalmers, J.N.M., Gillam, A.E., Kench, J.E.: Porphyrinuria in a case of industrial methyl chloride poisoning. The Lancet, Dec. 28, 806–807, 1940 CrossRefGoogle Scholar
  7. [7]
    Chang, K-J., Lu, F-J., Tung, T-C, Lee, T-P.: Studies on patients with polychlorinated biphenyl poisoning. Res. Commun. Chem. Path. Pharmacol. 30, 547–544, 1980 Google Scholar
  8. [8]
    Debets, F.M.H., Strik, J.J.T.W.A., Olie, K.: Effects of pentachlorophenol on rat liver changes induced by hexachlorobenzene, with special reference to porphyria, and alterations in mixed function oxygenases. Toxicol. 15, 181–195, 1980 CrossRefGoogle Scholar
  9. [9]
    Dogramaci, I.: Porphyrias and porphyrin metabolism with special reference to porphyria in childhood. Adv. Pedriatr. 13, 11–63, 1964 Google Scholar
  10. [10]
    Doss, M. Porphyrie. In: Labor und Diagnose. Herausgeb. L. Thomas, Die Medizin. Verlagsgesellschaft Marburg 1988, pp. 501–529. Google Scholar
  11. [11]
    Haeger-Aronsen, B.: Why is the patient with lead intoxication not light sensitive? Acta Dermatovener (Stockholm) Suppl. 100, 67–71, 1982 Google Scholar
  12. [12]
    Hastka, J., Lasserre, J.-J., Schwarzbeck, A., Hehlmann, R.: Central role of Zinc protoporphyrin in staging iron deficiency. Clin. Chem. 40, 768–773, 1994 Google Scholar
  13. [13]
    Jirasek, L., Kalensky, J., Kubec, K., Pazderova, J., Lukas, E.: Chlorakne, Porphyria cutanea tarda und andere Intoxikationen durch Herbizide. Hautarzt 27, 328–333, 1976 Google Scholar
  14. [14]
    Jung, D., Konietzko, J., Rull-Konietzko, G., Muttray, A., Zimmermann-Hölz, H.-J., Doss, M., Beck, H., Edler, L., Kopp-Schneider, A.: Porphyrin studies in TCDD-exposed workers, Arch. Toxicol. 68, 595–598, 1994 CrossRefGoogle Scholar
  15. [15]
    Kimmig, J., Schulz, K.H.: Berufliche Akne (sog. Chlorakne) durch chlorierte aromatische zyklische Äther. Dermatologica (Basel) 115, 540–546, 1957 CrossRefGoogle Scholar
  16. [16]
    Koss, G., Döring, H., Stremme, C, Seubert, S., Seubert, A., Arndt, B., Seidel, J., Koransky, W., Ippen, H.: Elimination of porphyrins and their precursors in rats pretreated with hexabromobenzene. Ed. Chem. Toxicol. 24, 325–328, 1986 CrossRefGoogle Scholar
  17. [17]
    Koss, G., Meyer-Rogge, D., Seubert, S., Seubert, A., Losekam, M.: 2,′, 3′, 4, 4′, 5, 5′-heptachlorobiphenyl (PCB 180) — on its toxicokinetics, biotransformation and porphyrinogens action infernale rats. Arch. Toxicol. 67, 651–654, 1993 CrossRefGoogle Scholar
  18. [18]
    Koss, G., Seubert, S., Seubert, A., Seidel Koransky, W., Ippen, H.: Studies on the toxicology of hexachlorobenzene. V. Different phases of porphyria during and after treatment. Arch.Toxicol. 52, 13–22, 1983 CrossRefGoogle Scholar
  19. [19]
    Koss, G., Stella, A.M., Melito, V., Parera, V., Guolo, M, Magnin, P.H., del C. Battle, A.M.: Hexaclorobenceno y pentaclorofe-nol en tijido adiposo y orina de un nino con porfiria cutanea tardia. Evaluacion del tratamiento (S-adenosil-I-metionina y bajas dosis de cloroquina) a 4 anos de iniciado el mismo. Rev. Arg. Derm. 74, 30–36, 1993 Google Scholar
  20. [20]
    Koss, G., Stoffelns, B., Seubert, S., Seubert, A., Koransky, W., Ippen, H.: Time-course and extent of disturbance of the hepatic porphyrin pathway in hexachlorobenzene-exposedfemale rats. In: IARC Scientific Publ. 77, C. R. Morris J. R. P. Cabrai , eds., pp. 493–495 (Lyon 1986) Google Scholar
  21. [21]
    Koss, G. Weider, T. S. Seubert, A., Seubert, A.: 2, ′, 4, 4′, 5, 5’-hexabromobiphenyl: its toxikokinetics, biotransformation and porphyrinogens action in rats. Fd. Chem. Toxic. 32, 605–610, 1994 CrossRefGoogle Scholar
  22. [22]
    Kreiss, K., Roberts, C., Humphrey, H.E.B.: Serial PBB levels, PCB levels, and clinical chemistries in Michigan’s PBB cohort. Arch. Environ. Hlth. 37, 141–147, 1982 CrossRefGoogle Scholar
  23. [23]
    Krüger, C, Fürst, P., Groebel, W.: Nachweis und Bestimmung von polybromierten Biphenylen in Frauenmilch. Dt. Lebens. Rdsch. 88, 273–276, 1988 Google Scholar
  24. [24]
    Lange, C.E., Bloch, H., Veltman, G., Dass, M.: Urinary porphyrins among PVC workers. In: Porphyrins in human diseases. Ed.: Doss, M. , Karger, Basel 1976 pp. 352–355 Google Scholar
  25. [25]
    Lynch, R.E., Lee, G.R., Kushner, J.P.: Porphyria cutanea tarda associated with disinfectant misuse. Arch. Intern. Med. 135, 549–552, 1975 CrossRefGoogle Scholar
  26. [26]
    McConnell, R., Anderson, K., Russell, W., Anderson, K.E., Clapp, R., Silbergeld, E.K., Landrigan, P.J.: Angiosarcoma, porphyria cutanea tarda, and probale chloracne in a worker exposed to waste oil contaminated with 2.3.7,8-tetrachlorodibenzo-p-dioxin. Brit. J. Ind. Med. 50, 699–703, 1993 Google Scholar
  27. [27]
    Moore, M.R., Dover, S.B., Fitzsimons, E.J., McColl, K.E.L.: Porphyria, acute porphyria-drug lists. Booklet. Porphyrias Research Unit. University Department of Medicine and Therapeutics. Glasgow G 11 GN/Schottland. 1994 Google Scholar
  28. [28]
    Moore, M.R., Goldberg, A., Yeung-Laiwah, A.A.C.: Lead effects on the heme biosynthetic pathway. Annals NY Acad. Sci. 514, 191–203, 1987 CrossRefGoogle Scholar
  29. [29]
    Peters, H., Cripps, D., Göcmen, A., Bryan, G. Ertürk, E., Morris, C.: Turkish epidemic hexachlorobenzene porphyria — a 30-year study. Ann. NY Acad. Sci. 514, 183–190, 1987 CrossRefGoogle Scholar
  30. [30]
    Silbergeld, E., Fowler, B.L.A.: Mechanisms of chemical-inducedporphyrinopathies. Ann. NY Acad. Sci. 514, 1987 Google Scholar
  31. [31]
    Strik, J.J.T.W.A., Doss, M., Schraa, G., Robertson, L.W., von Tiepermann, Harmsen, E.G.M.: Coproporphyrinuria and chronic hepatic porphyria type A found in farm families from Michigan, USA exposed to polybrominated biphenyls (PBB). In: Chemical Porphyria in Man, Strik, J.J. T. W.A., Koeman, J.H. (Ed.), Elsevierl North-Holland Biomedical Press, 1979, pp. 29–53 Google Scholar
  32. [32]
    Strohmeyer, G. Störungen des Porphyrinstoffwechsels. In: Lehrbuch der inneren Medizin. Herausgeb. W. Siegenthaler, W. Kaufmann, H. Hornbostel, H.D. Waller . Georg Thieme Verlag Stuttgart, New York 1992, pp. 1330–1342 Google Scholar
  33. [33]
    WHO: Polychlorinated Biphenyls and Terphenyls. Sec. Edition. Environmental Health Criteria 140, Genf 1993 Google Scholar
  34. [34]
    Peters, H.A. et al.: Hexachlorbenzene-induced porphyria — effect of chelation on the disease, porphyrin and metal metabolism. Amer J. Med. Sci 251, 314–322, 1966. CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • G. Koss

There are no affiliations available

Personalised recommendations